Patents by Inventor Matthew John Lindon

Matthew John Lindon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
    Patent number: 9663533
    Abstract: Thienopyridone compounds of formula (I): or a salt thereof, pharmaceutical compositions containing such compounds and their use in therapy, in particular in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: May 30, 2017
    Assignee: GlaxoSmithKline LLC
    Inventors: Dominique Amans, Paul Bamborough, Rino Antonio Bit, John Alexander Brown, Matthew Campbell, Matthew John Lindon, Tracy Jane Shipley, Natalie Hope Theodoulou, Christopher Roland Wellaway, Susan Marie Westaway
  • THIENO[3,2-C]PYRIDIN-4(5H)-ONES AS BET INHIBITORS
    Publication number: 20160297832
    Abstract: Thienopyridone compounds of formula (I): or a salt thereof, pharmaceutical compositions containing such compounds and their use in therapy, in particular in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 13, 2016
    Inventors: Dominique AMANS, Paul BAMBOROUGH, Rino Antonio BIT, John Alexander BROWN, Matthew CAMPBELL, Matthew John LINDON, Tracy Jane SHIPLEY, Natalie Hope THEODOULOU, Christopher Roland WELLAWAY, Susan Marie WESTAWAY
  • Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain
    Patent number: 7285563
    Abstract: The present invention provides compounds of formula (I); pharmaceutically acceptable salts and N-oxides thereof in which A, B, D and E are C or N with the proviso that one or more are N, R1, R2, R3, R4, R5 and R6 are simple substituents, n is 0-3 and y is an aryl, heteroaryl, carbocyclyl or fused-carbocyclyl group; as VR-1 antagonists for treating conditions or diseases in which pain and/or inflammation predominates; the use of the same for manufacturing medicaments, pharmaceutical compositions comprising them and methods of treatment utilizing them
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: October 23, 2007
    Inventors: Rebecca Elizabeth Brown, Victoria Alexandra Doughty, Gregory John Hollingworth, A. Brian Jones, Matthew John Lindon, Christopher Richard Moyes, Lauren Rogers